NKILA is induced in activated T cells by STAT1 (signal transducer and activator of transcription 1) in a calcium/calmodulin-dependent fashion and promotes AICD in tumor-specific cytotoxic T lymphocytes and T helper cells type 1 (TH1) via the inhibition of the NF-κB pathway. This evidence concerns the gene NKILA and neoplasm.